Allogene Therapeutics
California, United States
501-1,000 Employees
Automotive
•Healthcare
•Tech
Director, Clinical Portfolio and Program Management
--
Anywhere Full time
Description
Allogene Therapeutics is a biotechnology company focused on developing allogeneic CAR T-cell therapies for the treatment of cancer. The company aims to revolutionize cancer treatment by harnessing the power of the immune system to create off-the-shelf CAR T-cell therapies that can be readily available to patients.
Financials
Type
public
Annual Revenue
--
Market Cap
$365.0M+
Subscribe to Refer Me premium to get referred to this role at Allogene Therapeutics!
